DEBUG INFO [ON] Page template: HIVnetChild_menu_nosidebar.php Search terms :
Since its inception in 1990, the CTN has built a world-class national infrastructure that ensures Canadian HIV researchers collaborate locally and internationally to improve health outcomes, train the next generation of postdoctoral fellows, and lead cutting edge patient-oriented research in HIV and related conditions.
At the heart of the CTN is the National Centre, based in Vancouver. This site facilitates and supports research across Canada by efficiently centralizing administrative, methodological and management services, including communications and knowledge translation.
The CTN facilitates HIV trials and research studies through a network of 49 research clinics and hospitals in Canada and an additional 15 international sites. The National Centre located in Vancouver, BC, provides clinical research services to investigators and administrative support to the network.
The Cores are responsible for managing the flow of concept development to protocols, supervising ongoing studies and mentoring junior investigators. In addition to reaching out to colleagues and sites across Canada, all four Cores are committed to working in partnership with individuals and clinical trial networks globally.
CTN committees meet to review protocols, monitor trials in progress, set priorities and debate policy. They also advise the Steering Committee ensuring that all trials maintain the highest scientific and ethical standards. In addition to its standing committees, the CTN has a number of ad hoc committees and working groups on topics such as ethics review, postdoctoral fellowships, international research, and cohort studies.
The average age of people living with HIV in Canada is rising. CTN and BC-CfE researchers are working to understand the factors associated with aging in HIV. This story was originally published by BC-CfE.
Dr. Haneesha Mohan, CTN Postdoctoral Research Fellow at the University Health Network, describes her work on understanding the metabolic diseases and birth defects potentially caused by ARV medications.
We talked to three community members to get their unique perspectives on the pervasive impact of HIV-related stigma and what we can do to combat it
CTN Investigators Drs. Cecilia Costiniuk and Ali Jenabian publish a thorough editorial review of cannabis research in HIV and inflammation
2014 © CIHR Canadian HIV Trials Network
